【丹麦】诺和诺德基金会与英伟达联手，宣布将在丹麦建设一座名为Gefion的AI超级计算机，旨在加速新药和疗法的创新研发。据科创板日报报道，这一合作项目将充分利用英伟达的先进AI技术，为丹麦的公共和私营部门的研究者提供强大的计算资源。
诺和诺德基金会，作为知名制药企业诺和诺德背后的支持力量，此次与全球领先的GPU技术和AI解决方案提供商英伟达合作，显示出对人工智能在医疗健康领域应用的高度重视。Gefion超级计算机的建立，预期将极大地提升药物研发的效率，为应对各种疾病挑战开辟新的路径。
这台AI超级计算机将专为新药发现和疗法开发设计，通过高速处理大量数据，帮助科学家们更快地识别潜在的治疗靶点，并进行模拟和预测，从而缩短药物研发周期。该项目的实施不仅将推动丹麦的科研实力，还有望对全球医药行业产生深远影响。
诺和诺德基金会与英伟达的这一合作，是科技与医疗结合的又一里程碑，彰显了科技在解决全球健康问题中所发挥的关键作用。随着Gefion的建设进程，我们期待未来能见证更多创新药物和疗法的诞生，为全球患者的福祉带来实质性的改善。
英语如下：
**News Title:** “Novo Nordisk Foundation and NVIDIA Team Up: Building an AI Supercomputer to Revolutionize Drug Discovery”
**Keywords:** AI Supercomputer, Novo Nordisk, Drug Discovery
**News Content:**
The Novo Nordisk Foundation, in collaboration with NVIDIA, has announced plans to construct an AI supercomputer named Gefion in Denmark, aimed at accelerating innovation in drug and therapy development. According to the科创板 Daily, this partnership will harness NVIDIA’s advanced AI technology, providing powerful computational resources to researchers in both Denmark’s public and private sectors.
The Novo Nordisk Foundation, the driving force behind the renowned pharmaceutical company Novo Nordisk, demonstrates its high regard for AI applications in healthcare through this partnership with NVIDIA, a global leader in GPU technology and AI solutions. The establishment of the Gefion supercomputer is expected to significantly enhance the efficiency of drug development, paving new ways to address various disease challenges.
Tailored specifically for new drug discovery and therapy development, the AI supercomputer will facilitate the rapid processing of vast amounts of data, enabling scientists to identify potential therapeutic targets more quickly and conduct simulations and predictions, thereby shortening the drug development timeline. This project not only boosts Denmark’s research capabilities but also has the potential to exert a profound impact on the global pharmaceutical industry.
This collaboration between the Novo Nordisk Foundation and NVIDIA represents another milestone in the convergence of technology and healthcare, emphasizing the crucial role of technology in addressing global health issues. As the construction of Gefion progresses, we look forward to witnessing the birth of more innovative drugs and therapies that will bring substantial improvements to the well-being of patients worldwide.
【来源】https://www.chinastarmarket.cn/detail/1624366
Views: 1